Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: A randomized controlled clinical trial

Joanne M. Langley, Louise Frenette, Robert Jeanfreau, Scott A. Halperin, Michael Kyle, Laurence Chu, Shelly McNeil, Mamadou Dramé, Philippe Moris, Louis Fries, David W. Vaughn

Research output: Contribution to journal › Article › peer-review

14 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: A randomized controlled clinical trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology